Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

324 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Imatinib mesylate in the treatment of diffuse cutaneous mastocytosis.
Morren MA, Hoppé A, Renard M, Debiec Rychter M, Uyttebroeck A, Dubreuil P, Martin L. Morren MA, et al. Among authors: debiec rychter m. J Pediatr. 2013 Jan;162(1):205-7. doi: 10.1016/j.jpeds.2012.08.035. Epub 2012 Oct 13. J Pediatr. 2013. PMID: 23069194
Biallelic inactivation of NF1 in a sporadic plexiform neurofibroma.
Beert E, Brems H, Renard M, Ferreiro JF, Melotte C, Thoelen R, De Wever I, Sciot R, Legius E, Debiec-Rychter M. Beert E, et al. Among authors: debiec rychter m. Genes Chromosomes Cancer. 2012 Sep;51(9):852-7. doi: 10.1002/gcc.21969. Epub 2012 May 14. Genes Chromosomes Cancer. 2012. PMID: 22585738
PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis.
Arts FA, Sciot R, Brichard B, Renard M, de Rocca Serra A, Dachy G, Noël LA, Velghe AI, Galant C, Debiec-Rychter M, Van Damme A, Vikkula M, Helaers R, Limaye N, Poirel HA, Demoulin JB. Arts FA, et al. Among authors: debiec rychter m. Hum Mol Genet. 2017 May 15;26(10):1801-1810. doi: 10.1093/hmg/ddx081. Hum Mol Genet. 2017. PMID: 28334876
GIST under imatinib therapy.
Sciot R, Debiec-Rychter M. Sciot R, et al. Among authors: debiec rychter m. Semin Diagn Pathol. 2006 May;23(2):84-90. doi: 10.1053/j.semdp.2006.08.005. Semin Diagn Pathol. 2006. PMID: 17193821 Review.
A potent combination of the novel PI3K Inhibitor, GDC-0941, with imatinib in gastrointestinal stromal tumor xenografts: long-lasting responses after treatment withdrawal.
Floris G, Wozniak A, Sciot R, Li H, Friedman L, Van Looy T, Wellens J, Vermaelen P, Deroose CM, Fletcher JA, Debiec-Rychter M, Schöffski P. Floris G, et al. Among authors: debiec rychter m. Clin Cancer Res. 2013 Feb 1;19(3):620-30. doi: 10.1158/1078-0432.CCR-12-2853. Epub 2012 Dec 11. Clin Cancer Res. 2013. PMID: 23231951 Free PMC article.
324 results